Despite operational challenges, the ratings of U.S. healthcare companies will remain overall stable in 2012, with some downward pressure in branded pharmaceutical company ratings and upward momentum in hospital provider ratings, according to a Fitch Ratings release.
Fitch also forecasts 3.9 percent revenue growth and 1.2 percent EBITDA growth across its ratings portfolio for 2012, with weak organic trends in the utilization of healthcare services and products.
Slightly positive growth despite a weak operating environment will be supported by greater demand growth in emerging markets, new product launches and an active acquisition environment.
Fitch also forecasts 3.9 percent revenue growth and 1.2 percent EBITDA growth across its ratings portfolio for 2012, with weak organic trends in the utilization of healthcare services and products.
Slightly positive growth despite a weak operating environment will be supported by greater demand growth in emerging markets, new product launches and an active acquisition environment.
Related Articles on Healthcare Trends:
4 Trends in Hospital CFO Compensation
Healthcare Private Equity: Opportunities, Outlook for 2012
7 Points on Cost Containment and the State of Medicaid